Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells

被引:0
作者
Sammy Bedoui
Paul G Whitney
Jason Waithman
Liv Eidsmo
Linda Wakim
Irina Caminschi
Rhys S Allan
Magdalena Wojtasiak
Ken Shortman
Francis R Carbone
Andrew G Brooks
William R Heath
机构
[1] The University of Melbourne,The Department of Microbiology and Immunology
[2] The Walter and Eliza Hall Institute of Medical Research,undefined
来源
Nature Immunology | 2009年 / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The functions of individual dendritic cell subsets in the skin are unclear. Heath and colleagues now show that langerin-positive CD103+ dermal dendritic cells are the main migratory subtype able to cross-present antigen.
引用
收藏
页码:488 / 495
页数:7
相关论文
共 94 条
[31]  
Wilson NS(2003)Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity Eur. J. Immunol. 33 1879-1888
[32]  
He Y(2003)Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells J. Exp. Med. 197 153-162
[33]  
Zhang J(2009)Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity J. Exp. Med. 206 359-370
[34]  
Donahue C(2006)Dynamics and function of Langerhans cells in vivo dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells Proc. Natl. Acad. Sci. USA 103 7783-7788
[35]  
Falo LD(2000)Identification of a novel population of Langerin J. Exp. Med. 192 1685-1696
[36]  
Bennett CL(2006) dendritic cells J. Immunol. 176 2161-2172
[37]  
Waithman J(2008)The dermis contains langerin Science 322 1097-1100
[38]  
Kaplan DH(2008) dendritic cells that develop and function independently of epidermal Langerhans cells J. Exp. Med. 205 1621-1634
[39]  
Jenison MC(2007)Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state J. Immunol. 178 6861-6866
[40]  
Saeland S(2008)Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease J. Immunol. Methods 337 121-131